A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101R. Michael Baldwin, Deanna L. Kroetz, Kouros Owzar et al.|Clinical Cancer Research|2012Cited by 206
Integration of Cell Line and Clinical Trial Genome-Wide Analyses Supports a Polygenic Architecture of Paclitaxel-Induced Sensory Peripheral NeuropathyHeather E. Wheeler, Mary Eileen Dolan, Eric R. Gamazon et al.|Clinical Cancer Research|2012Cited by 59
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a <i>VAC14</i> Polymorphism that Increases Risk of Docetaxel-Induced NeuropathyDaniel L. Hertz, Howard L. McLeod, Kouros Owzar et al.|Clinical Cancer Research|2016Cited by 57
A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469Jacqueline Ramı́rez, Mark J. Ratain, Tae Won Kim et al.|Pharmacogenetics and Genomics|2013Cited by 15
Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance)Lynn G. Dressler, Howard L. McLeod, Allison M. Deal et al.|JNCI Journal of the National Cancer Institute|2015Cited by 9